タンパク質分解のための二重受容体ライソーム標的キメラの開発
Kun Wang1, Ke Wang2, Cong Wang2
1State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
Journal of the American Chemical Society
|October 23, 2025
まとめ
この研究は,PD-L1やEGFRのような病気を引き起こすタンパク質を分解するために,ライソーム標的化キメラ (LYTAC) を使用した二重標的化戦略を導入しています. この新しいアプローチは 標的型タンパク質の分解を 潜在的がん治療法として強化します
科学分野:
- 生物化学
- 分子生物学
- 腫瘍学
背景:
- リソソーム標的キメラ (LYTAC) は,標的型タンパク質分解のための新興治療法である.
- 現在のLYTAC戦略は,特定の細胞外および膜タンパク質を分解する際の制限に直面しています.
研究 の 目的:
- リソソームを標的とする新しい受容体依存タンパク質分解戦略を開発する.
- プログラム細胞死リガンド1 (PD-L1) と表皮成長因子受容体 (EGFR) の効率的な分解のための二重受容体LYTACsを作成する.
主な方法:
- C- X- Cキモカイン受容体4 (CXCR4) と葉酸受容体1 (FOLR1) のシネージ的作用を活用した.
- PD-L1とEGFRの分解のために設計され,テストされた二重受容体LYTACs.
- EGFR駆動肺がんの臨床前モデルで評価された有効性.
主要な成果:
- 二重受容体LYTACを用いてPD- L1とEGFRの効率的な分解を達成した.
- EGFRを標的にするキメラは,薬剤耐性肺がん腫瘍の成長を有意に抑制することが示された.
- 単一受容体LYTACと比較して,ダブルターゲティング戦略は優れたタンパク質分解を示した.
結論:
- ダブルターゲティングのLYTAC戦略は,タンパク質の分解能力を向上させます.
- この新しいプラットフォームは 先進的な癌治療薬の開発に 期待されています
- 二重受容体の標的化は 疾患の治療におけるタンパク質分解の戦略における 重要な進歩を意味します
関連する概念動画
Regulated Protein Degradation
8.7K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
8.7K
Delivery Pathways to the Lysosome
8.8K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
8.8K
Lysosomal Hydrolases
4.4K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.4K
Receptor-mediated Endocytosis
110.5K
Overview
110.5K
Receptor-mediated Endocytosis
7.5K
Receptor-mediated endocytosis is when bulk amounts of specific molecules are imported into a cell after binding to cell surface receptors. The molecules bound to these receptors are taken into the cell through inward folding of the cell surface membrane, which is eventually pinched off into a vesicle within the cell. Structural proteins, such as clathrin, coat the budding vesicle.
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
7.5K
Export of Misfolded Proteins out of the ER
5.0K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
5.0K


